NATIONAL SCIENCE FOUNDATION
TOKYO REGIONAL OFFICE
February 20, 2004
The National Science Foundation's Tokyo Regional Office periodically reports on developments in Japan that are related to the Foundation's mission. It also provides occasional reports on developments in other East Asian countries.
Tokyo Office Report Memoranda are intended to provide information for the use of NSF program officers and policy makers; they are not statements of NSF policy.
Report Memorandum #04-03
The following workshop attendance report was prepared by Ms. Kazuko Shinohara of the National Science Foundation’s Tokyo Regional Office. She can be reached at kshinoha@nsf.gov
JFY2004 S&T-related Budgets BY PROJECT
This is to follow up the CSTP’s (Council for Science and Technology Policy) rating (http://www.nsftokyo.org/rm03-10.html) on Science and Technology-related budgets for JFY 2004. Based on the CSTP’s rating and responses from the ministries/agencies, the Ministry of Finance made the final decision on the JFY2004 budgets at the end of December 2003. The quick summary for S&T-related budgets for JFY2004 was reported on http://www.nsftokyo.org/rm04-02.html This is to report the S&T-related budgets for JFY2004 by project.
The budgets for the projects rated S, A, B, and C in JFY2004 have increased from those for JFY2003 as follows:
S: +16.7%
A: +5.9%
B: -2.8%
C: -20.8%
These increase rates show that the rating made by CSTP was reflected on the Ministry of Finance’s final decision.
S&T-related Budgets for JFY2004 BY PROJECT
Blue-colored figures: Not all the budgets are used solely for the project.
|
|
JFY2004 Budget |
JFY2004 Request |
JFY2003 Budget |
||
|
Ministry |
Yen Million |
Yen Million |
Yen Million |
||
|
BASIC SCIENCE |
|||||
|
A |
COE Program in the 21st Century |
MEXT |
36,727 |
41,746 |
33,383 |
|
A |
Private University Education and Research (S&T portion only) |
MEXT |
169,694 |
176,164 |
169,917 |
|
A |
High intensity proton accelerator (first phase) |
MEXT |
19,382 |
20,528 |
16,447 |
|
C |
High intensity proton accelerator (part of the second phase) |
MEXT |
19,382 |
20,528 |
|
|
A |
Joint use of Spring-8 |
MEXT |
11,427 |
12,471 |
11,242 |
|
A |
ALMA |
MEXT |
1,003 |
1,081 |
0 |
|
LIFE SCIENCE |
|||||
|
A |
Tailor-made medical care |
MEXT |
2,650 |
2,650 |
2,152 |
|
A |
Human genome/genetic treatment |
MHLW |
2,179 |
2,118 |
2,118 |
|
A |
Regenerative medical treatment |
MEXT |
1,235 |
1,300 |
1,300 |
|
A |
Human genome/regenerative medicare |
MHLW |
933 |
1,167 |
993 |
|
S |
Genome network |
MEXT |
3,000 |
8,000 |
0 |
|
A |
Protein 3000 |
MEXT |
9,050 |
9,856 |
9,512 |
|
A |
Disease-related protein analyses |
MHLW |
662 |
3,500 |
500 |
|
B |
Mental health |
MHLW |
1,756 |
1,993 |
1,898 |
|
B |
Food allergy |
MHLW |
0 |
30 |
0 |
|
A |
Advancement of food safety |
MHLW |
1,527 |
1,772 |
1,477 |
|
A |
Food safety and functions |
MAFF |
1,041 |
2,007 |
828 |
|
A |
Physical function analyses/aid and replacement tools |
MHLW |
700 |
700 |
700 |
|
B |
Pharmaceutical/medical equipment regulatory science |
MHLW |
1,410 |
1,692 |
1,409 |
|
S |
National Bio Resource Project |
MEXT |
1,672 |
1,672 |
4,000 |
|
A |
Clinical application of basic research |
MHLW |
2,116 |
2,800 |
1,750 |
|
B |
Toxicogenomics |
MHLW |
1,176 |
1,272 |
1,271 |
|
B |
Immune allergy prevention/treatment |
MHLW |
1,105 |
1,194 |
1,137 |
|
S |
Cancer translational research (clinical) |
MEXT |
1,000 |
2,500 |
0 |
|
A |
Translational research program (clinical) |
MEXT |
2,394 |
2,845 |
2,845 |
|
B |
Highly advanced analyses technology development (clinical) |
MEXT |
2,394 |
2,845 |
2,845 |
|
B |
Human sciences including pharmaceuticals |
MHLW |
2,528 |
2,576 |
2,576 |
|
C |
Environment-friendly next-generation agricultural production system |
MAFF |
354 |
1,009 |
0 |
|
B |
Cultivation/distribution/processing technologies of new species |
MAFF |
1,096 |
1,587 |
1,184 |
|
C |
Secondary metabolic products |
MAFF |
0 |
1,587 |
0 |
|
S |
Rice genome: important characteristics-related genes |
MAFF |
723 |
723 |
723 |
|
B |
Rice genome: comparison between species |
MAFF |
121 |
122 |
122 |
|
B |
Rice genome: rice genome simulator |
MAFF |
250 |
321 |
321 |
|
A |
Rice genome: DNA marker |
MAFF |
474 |
474 |
474 |
|
A |
Rice genome: gene isolation/function analyses |
MAFF |
746 |
748 |
748 |
|
A |
Rice genome: rice genome resource center |
MAFF |
87 |
87 |
87 |
|
A |
Rice genome: sequencing all base pairs |
MAFF |
723 |
723 |
723 |
|
B |
Agro-bio commercialization/industrialization |
MAFF |
1,004 |
4,580 |
0 |
|
S |
Third strategy for cancer |
MHLW |
4,633 |
5,020 |
4,183 |
|
A |
Cancer research subsidies |
MHLW |
1,850 |
1,850 |
1,850 |
|
C |
MHLW special scientific research |
MHLW |
1,741 |
17,562 |
2,013 |
|
B |
Cardiovascular disease |
MHLW |
1,298 |
1,533 |
1,298 |
|
A |
Medical technology |
MHLW |
1,718 |
2,002 |
1,668 |
|
A |
AIDS |
MHLW |
4,211 |
4,439 |
3,861 |
|
C |
SARS |
MHLW |
22 |
22 |
0 |
|
B |
Disease-model animals |
MHLW |
0 |
24 |
0 |
|
B |
Illegal pharmaceuticals and health damage by legal pharmaceuticals |
MHLW |
0 |
26 |
0 |
|
B |
Administrative policy research |
MHLW |
915 |
1,006 |
892 |
|
B |
Longevity research |
MHLW |
2,063 |
2,249 |
2,230 |
|
B |
Disease beyond medical treatment |
MHLW |
2,126 |
2,407 |
2,322 |
|
B |
Children and environment |
MHLW |
1,161 |
1,288 |
1,255 |
|
B |
Health science |
MHLW |
1,150 |
1,319 |
1,256 |
|
NA |
Human Frontier Science Program |
MEXT/METI |
2179/1279 |
2415/1418 |
2415/1418 |
|
INFORMATION TECHNOLOGY |
|||||
|
A |
Ubiquitous network |
MPMHAPT |
3,105 |
3,450 |
2,498 |
|
S |
Digital tag: advanced application technology |
MPMHAPT |
699 |
700 |
0 |
|
S |
Digital tag: diffusion |
METI |
3,000 |
3,500 |
0 |
|
B |
Optical radio and optical fiber |
MPMHAPT |
0 |
50 |
0 |
|
A |
Shift to Internet IPv6 (internet protocol version 6) |
MPMHAPT |
1,753 |
2,003 |
2,003 |
|
B |
IP phone in mobile environment |
MPMHAPT |
10 |
80 |
0 |
|
A |
IT in medical field |
METI |
1,494 |
1,962 |
0 |
|
A |
Electric resource development |
METI |
527 |
880 |
0 |
|
A |
Advanced network |
MPMHAPT |
1,040 |
1,300 |
0 |
|
B |
Mobile filtering technology |
MPMHAPT |
58 |
125 |
0 |
|
A |
Illegal access prevention |
METI |
674 |
1,000 |
0 |
|
B |
E-science project |
MEXT |
3,500 |
4,508 |
1,505 |
|
A |
E-society software |
MEXT |
1,100 |
1,202 |
1,202 |
|
A |
Digital archive of intelligent assets |
MEXT |
500 |
1,007 |
0 |
|
S |
Software engineering by industry-university collaboration |
METI |
1,482 |
2,750 |
0 |
|
A |
Voice translation system |
MPMHAPT |
730 |
950 |
530 |
|
S |
Network Robotics |
MPMHAPT |
730 |
950 |
0 |
|
A |
Robotics in construction |
MLIT |
158 |
159 |
159 |
|
B |
National research grid initiative |
MEXT |
1,950 |
3,202 |
2,002 |
|
A |
Business grid computing |
METI |
2,602 |
2,801 |
2,797 |
|
C |
Advanced computing for simulation |
MEXT |
0 |
2,000 |
0 |
|
B |
Network technology by use of nanotechnology |
MPMHAPT |
135 |
330 |
0 |
|
A |
EUV light source |
MEXT |
1,140 |
1,200 |
1,200 |
|
B |
IT program |
MEXT |
3,500 |
4,508 |
3,005 |
|
C |
Transportation service information system |
MLIT |
0 |
101 |
0 |
|
ENVIRONMENT |
|||||
|
A |
Dangers generated by new technologies |
MPMHAPT |
211 |
214 |
0 |
|
B |
Green house effect gas |
MEXT |
0 |
202 |
0 |
|
B |
Save-energy-type chemical technologies |
METI |
1,251 |
1,331 |
0 |
|
S |
CO2 isolation technologies |
METI |
350 |
350 |
0 |
|
B |
International projects on global environment |
METI |
1,368 |
1,474 |
1,209 |
|
A |
Next-generation environment-friendly car |
MLIT |
1,410 |
1,497 |
1,495 |
|
A |
Biomass fuel cell car |
MLIT |
135 |
150 |
0 |
|
S |
Next-generation super eco-ship |
MLIT |
564 |
707 |
326 |
|
B |
Regulations on ship 痴 effect on the environment |
MLIT |
76 |
88 |
0 |
|
C |
Environment-friendly buildings |
MLIT |
169 |
580 |
0 |
|
A |
Co-existence of human beings/nature/globe |
MEXT |
4,127 |
3,678 |
3,678 |
|
A |
Antarctic observation activities |
MEXT |
5,680 |
11,419 |
3,480 |
|
A |
Comprehensive processing/recycling of ordinary/industrial waste and biomass |
MEXT |
475 |
500 |
450 |
|
B |
Bio-recycle |
MAFF |
1,260 |
3,012 |
800 |
|
B |
Water quality and resources |
MAFF |
0 |
135 |
0 |
|
A |
Advanced building maintenance system |
METI |
50 |
100 |
0 |
|
A |
Nature-friendly land infrastructure |
MLIT |
294 |
323 |
323 |
|
B |
Urban space heat environment |
MLIT |
158 |
460 |
0 |
|
B |
Chemical substances in ecosystem |
MEXT |
0 |
311 |
0 |
|
A |
Food and Pharmaceuticals: chemical substance risk |
MHLW |
2,049 |
2,253 |
2,049 |
|
A |
Chemical substance risk management |
METI |
50 |
50 |
0 |
|
B |
Environment hormone risk evaluation/international projects |
ME |
1.275 |
2,002 |
1,288 |
|
A |
Environmental technologies using nanotechnology |
ME |
350 |
400 |
300 |
|
A |
Water management to cope with global water circulation |
MLIT |
75 |
104 |
104 |
|
NANOTECHNOLOGY |
|||||
|
A |
Artificial organs/sensors using nanotechnology |
MEXT |
77 |
80 |
152 |
|
C |
Digital device that senses organism information |
MEXT |
0 |
329 |
152 |
|
A |
Cell: devices that fit organisms |
MEXT |
355 |
361 |
0 |
|
S |
Nanomedicine |
MHLW |
1,303 |
2,140 |
1,203 |
|
A |
Comprehensive nanotechnology project |
MEXT |
2,803 |
2,950 |
2,908 |
|
A |
Commercialization of nano-measuring/processing technologies |
MEXT |
603 |
2,000 |
0 |
|
S |
Deterioration of facilities which house dangers |
MPMHAPT |
|||